Top Markets
#1 Nesa Nesa +817.87%
#2 Cortex Cortex +68.73%
#3 Kinesis Silver Kinesis Silver +57.40%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#5 QuantixAI QuantixAI +24.05%
#6 Cash Cat Cash Cat +23.89%
#7 EXOD EXOD +22.78%
#8 OpenEden OpenEden +19.19%
#9 Palladium Network Palladium Network +19.01%
#10 Instadapp Instadapp +16.15%
Coin of the day
Nesa Nesa
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Surrozen, Inc. Surrozen, Inc.

Surrozen, Inc.

SRZN
Hisse Senetlerindeki Sıralama #19467
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates... Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs’ endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Hisse Fiyatı
$21.57
Son senkronizasyon: 2026-07-31
Piyasa Değeri
$161.29M
Değişim (1 gün)
3.55%
Değişim (1 yıl)
94.32%
Ülke
US
Ticaret Surrozen, Inc. (SRZN)

Kategori

Healthcare
Surrozen, Inc. (SRZN) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $22.02 - 2026-07-01

Gün sonu en düşük fiyat: $154.45 - 2021-01-01
Surrozen, Inc. için hisse fiyatı geçmişi: 2021 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 0.48%
2025 90.61%
2024 37.87%
2023 6.62%
2022 -93.19%
2021 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $768.63 6.83%
CH